World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
33537
World Ranking
16917
National Ranking
254

Overview

Silke Gillessen is affiliated with the Universita della Svizzera Italiana in Switzerland and has an extensive record of research activities primarily within the field of Medicine. Their work spans multiple subfields, with a notable focus on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, and Cancer Research.

The main topics addressed in Silke Gillessen's research include:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Cancer, Lipids, and Metabolism
  • Testicular diseases and treatments
  • Urologic and reproductive health conditions
  • Bone health and treatments

Silke Gillessen's frequent collaborators are:

  • Karim Fizazi
  • Nicholas D. James
  • Christopher J. Sweeney
  • Bertrand Tombal
  • Fabio Turco

They have published extensively in leading medical journals, with recurrent appearances in:

  • European Urology
  • Annals of Oncology
  • Journal of Clinical Oncology
  • European Urology Open Science
  • European Urology Oncology

Some of the recent papers authored or co-authored by Silke Gillessen include:

  • EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent (2020, European Urology)
  • EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer (2020, European Urology)
  • Prostate cancer (2021, Nature Reviews Disease Primers)
  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020, Annals of Oncology)
  • EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent (2024, European Urology)

Silke Gillessen's research activities have contributed predominantly to prostate cancer knowledge in terms of diagnosis, local and metastatic treatment updates, as well as screening guidelines. Their work encompasses both clinical and applied medical research, with significant attention to radiopharmaceutical chemistry and cancer metabolism related to treatment strategies.

Best Publications

  • EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    Nicolas Mottet;Roderick C.N. van den Bergh;Erik Briers;Thomas Van den Broeck

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

    Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  • EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    Philip Cornford;Roderick C.N. van den Bergh;Erik Briers;Thomas Van den Broeck

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.: Annals of oncology : official journal of the European Society for Medical Oncology

    C. Parker;E. Castro;K. Fizazi;A. Heidenreich

  • Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.

    Elke Scandella;Ying Men;Silke Gillessen;Reinhold Förster

  • Differences in Dendritic Cells Stimulated in Vivo by Tumors Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor or Flt3-Ligand

    N Mach;S Gillessen;S B Wilson;C Sheehan

  • Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist

    Silke Gillessen;Daisy Carvajal;Ping Ling;Frank J. Podlaski

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    C. Parker;S. Gillessen;A. Heidenreich;A. Horwich

  • Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma

    Robert Soiffer;F Stephen Hodi;Frank Haluska;Ken Jung

  • Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

    Thomas Van den Broeck;Roderick C.N. van den Bergh;Nicolas Arfi;Tobias Gross

  • Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps

    Tiannan Guo;Petri Kouvonen;Ching Chiek Koh;Ludovic C Gillet

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

    N.W. Clarke;A. Ali;F.C. Ingleby;A. Hoyle

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid.

    L B Laudiero;L Aloe;R Levi-Montalcini;C Buttinelli

  • Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    J Beyer;P Albers;R Altena;J Aparicio

  • Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial

    Fred Saad;Joan Carles;Silke Gillessen;Axel Heidenreich

Frequent Co-Authors

Axel Heidenreich
Axel Heidenreich University of Cologne
Nicholas D. James
Nicholas D. James Institute of Cancer Research
Malcolm David Mason
Malcolm David Mason Cardiff University
Matthew R. Sydes
Matthew R. Sydes University College London
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Noel W. Clarke
Noel W. Clarke University of Salford
Chris Parker
Chris Parker Institute of Cancer Research
Stefano Fanti
Stefano Fanti University of Bologna
Fred Saad
Fred Saad University of Montreal
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t mean you have to follow the traditional path. Today, a variety of accredited online programs offer flexibility and career advancement for those interested in healthcare. If you are interested in pharmaceuticals, online pharmacy programs provide a convenient way to earn advanced qualifications—often at a lower cost.

For students interested in managing healthcare data and operations, consider earning a bachelor of health information management online. If you’re seeking a faster entry point into the field, billing and coding classes online offer short, targeted training for in-demand roles.

Nurses aiming to advance their careers will benefit from cheapest online acute care nurse practitioner programs, which prepare you for higher-level clinical roles and greater responsibility. These varied pathways are designed to fit different interests, schedules, and budgets, expanding opportunities within the constantly evolving healthcare industry.

Best Scientists Citing Silke Gillessen

Trending Scientists

Recently Published Articles